Sponsor:
Mayo Clinic
Code:
NCT07012135
Conditions
Multiple Sclerosis
Control Subjects
Autonomic Dysreflexia
Eligibility Criteria
Sex: All
Age: 18 - 50
Healthy Volunteers: Accepted
Interventions
Tests of sympathetic inhibition
Tests of sympathetic activation
Testing of autonomic dysreflexia
Brief summary:
Conditions
Multiple Sclerosis
Control Subjects
Autonomic Dysreflexia
Study ID
NCT07012135
Start date
Sep 17, 2025
Status verified date
May, 2026
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 50
Healthy Volunteers: Accepted
Enrollment
13 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Diagnostic
Arms
experimental: Individuals with multiple sclerosis
experimental: Individuals without multiple sclerosis
Interventions
Tests of sympathetic inhibition
Tests of sympathetic activation
Testing of autonomic dysreflexia
Primary outcome measure
Central contacts
Locations
Mayo Clinic
Recruiting
Rochester, Minnesota, United States, 55902
Contacts
Principal Investigator:
Ryan J. Solinsky, MD
Sponsor
Mayo Clinic
Last update posted
May 28, 2026
Last verified
May, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-05-28.